However, important questions remain as to how Drp1 dysregulation may interact with mitochondrial biogenesis and mitophagy and how the interactions affect mitochondrial quality control and are related to metabolic reprograming in breast cancer cells. This evidence concerns the gene DNM1L and breast carcinoma.